Literature DB >> 10539871

Secondary prevention trials for coronary artery disease with antibiotic treatment for Chlamydia pneumoniae: design issues.

J T Grayston1, L A Jackson, W J Kennedy, R A Kronmal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10539871     DOI： 10.1016/s0002-8703(99)70298-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  3 in total

1.  Prevention of coronary heart disease through treatment of infection with Chlamydia pneumoniae? Estimation of possible effectiveness and costs.

Authors:  C Sanderson; M Kubin
Journal:  Health Care Manag Sci       Date:  2001-12

2.  Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model.

Authors:  Andrei Kutlin; Patricia M Roblin; Margaret R Hammerschlag
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 3.  Weighing the evidence for infection as a risk factor for coronary heart disease.

Authors:  C J O'Donnell; D Levy
Journal:  Curr Cardiol Rep       Date:  2000-07       Impact factor: 2.931
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.